Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CPHRF NYSEARCA:THCX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHRFCipher Pharmaceuticals$9.44-1.7%$9.41$6.02▼$14.60N/AN/A14,119 shs22,388 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/A7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHRFCipher Pharmaceuticals-1.67%-1.77%-0.40%+19.04%+55.78%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPHRFCipher PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ATHCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHRFCipher Pharmaceuticals 0.00N/AN/AN/ATHCXAXS Cannabis ETF 2.54Moderate Buy$16.60N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHRFCipher PharmaceuticalsN/AN/AN/AN/AN/AN/ATHCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHRFCipher PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/A8/7/2025 (Estimated)THCXAXS Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPHRFCipher PharmaceuticalsN/AN/AN/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHRFCipher Pharmaceuticals25.09%THCXAXS Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipCPHRFCipher PharmaceuticalsN/ATHCXAXS Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHRFCipher Pharmaceuticals5N/AN/ANot OptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableCPHRF and THCX HeadlinesRecent News About These CompaniesChristina Lake Cannabis Announces Delay in Filing its 2024 Annual Financial StatementsJuly 3, 2025 | globenewswire.comTHC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis CompaniesJune 24, 2025 | prismmediawire.comPAurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 RevenuesJune 22, 2025 | seekingalpha.comWM Technology Is A Good Stock For Cannabis InvestorsJune 22, 2025 | seekingalpha.comAurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)June 18, 2025 | seekingalpha.comAurora Cannabis: Poised For Its First Profitable YearJune 16, 2025 | seekingalpha.comAurora Cannabis: Underappreciated TurnaroundMay 25, 2025 | seekingalpha.comI Still Like Village Farms For Cannabis Investors Despite The Big RallyMay 19, 2025 | seekingalpha.comVireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger TransactionsMay 12, 2025 | globenewswire.comChristina Lake Cannabis Closes First Tranche of Non-Brokered Private PlacementApril 30, 2025 | globenewswire.comHave Cannabis Investors Been Early Or Wrong Or Both?April 22, 2025 | seekingalpha.comLEEF Brands Begins Planting Salisbury Canyon Ranch, One of the Largest Cannabis Farms in the WorldApril 17, 2025 | globenewswire.comNew Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic FutureApril 16, 2025 | businesswire.comScotts Miracle-Gro Cutting Ties with Cannabis Investments for Now as Federal Legalization StallsApril 10, 2025 | wsj.comScottsMiracle-Gro Continues to Advance Consumer and Cannabis StrategiesApril 10, 2025 | globenewswire.comCannabis Edibles Market Report 2024-2034 Featuring BellRock Brands, Canna River, Wana, Copperstate Farms, Kiva Confections, Wyld, Plant Jam, Dixie Elixirs, Naturecan, Coda Signature, Bhang, UncrateApril 10, 2025 | globenewswire.comHYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German MarketMarch 28, 2025 | globenewswire.comCresco Labs to Operate Kentucky's Largest Medical Cannabis Cultivation LicenseMarch 10, 2025 | businesswire.comOrganigram Reports In-Line Q1 Results As Cannabis Sector TanksFebruary 23, 2025 | seekingalpha.comAurora Cannabis: This Phoenix Has Risen From The Ashes (Strong Buy Initiation)February 22, 2025 | seekingalpha.comMedia Sentiment Over TimeCPHRF and THCX Company DescriptionsCipher Pharmaceuticals OTCMKTS:CPHRF$9.44 -0.16 (-1.67%) As of 07/11/2025 03:27 PM EasternCipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
